Skip to main content
Top
Literature
1.
go back to reference Karatas F, Erdem GU, Sahin S et al (2017) Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients. Breast (Edinb Scotl) 32:237–244CrossRef Karatas F, Erdem GU, Sahin S et al (2017) Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients. Breast (Edinb Scotl) 32:237–244CrossRef
Metadata
Title
Obesity’s impact on survival is independent of dose adjustments in neoadjuvant chemotherapy in women with breast cancer
Authors
Ying L. Liu
Eileen P. Connolly
Kevin Kalinsky
Publication date
01-02-2018
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4590-0

Other articles of this Issue 1/2018

Breast Cancer Research and Treatment 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine